DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PROGESTERONE

« Back to Dashboard

Clinical Trials for Progesterone

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000175	The Effects of Sex Hormones on Cognition and Mood in Older Adults	Terminated	National Institute on Aging (NIA)	N/A	This study is investigating the effects of hormone replacement therapy on memory, mental abilities and mood in older adults aged 65-90. During the nine month long study, men will take testosterone for three months and women will take estrogen for three months. At four points during the study (once every three months), participants will complete a test battery and have blood drawn.
NCT00000176	Alzheimer's Disease Prevention Trial	Completed	National Institute on Aging (NIA)	Phase 3	This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.
NCT00000295	Progesterone Treatment in Female Smokers - 12	Completed	University of Minnesota - Clinical and Translational Science Institute	Phase 2	The purpose of this study is to investigate progesterone effects in female smokers
NCT00000295	Progesterone Treatment in Female Smokers - 12	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	The purpose of this study is to investigate progesterone effects in female smokers
NCT00000466	Postmenopausal Estrogen/Progestin Interventions (PEPI)	Completed	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Phase 3	To assess the effects of various postmenopausal estrogen replacement therapies on selected cardiovascular risk factors, including high density lipoprotein cholesterol, systolic blood pressure, fibrinogen, and insulin and on osteoporosis risk factors. Conducted in collaboration with the National Institute of Child Health and Human Development, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, The National Institute of Diabetes and Digestive and Kidney Diseases, and the National Institute on Aging. The extended follow-up is for 3 years focusing on endometrium and breast evaluation.

Clinical Trial Conditions for Progesterone

Condition Name

Condition Name for Progesterone
Intervention	Trials
Breast Cancer	136
Infertility	106
Polycystic Ovary Syndrome	31
Stage IV Breast Cancer	23

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Progesterone
Intervention	Trials
Breast Neoplasms	225
Infertility	128
Premature Birth	57
Polycystic Ovary Syndrome	43

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Progesterone

Trials by Country

Trials by Country for Progesterone
Location	Trials
United Kingdom	71
Egypt	55
Italy	50
Spain	47
China	42

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Progesterone
Location	Trials
California	105
New York	95
Texas	83
Illinois	75
Florida	70

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Progesterone

Clinical Trial Phase

Clinical Trial Phase for Progesterone
Clinical Trial Phase	Trials
Phase 4	152
Phase 3	173
Phase 2/Phase 3	32

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Progesterone
Clinical Trial Phase	Trials
Completed	311
Recruiting	201
Not yet recruiting	80

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Progesterone

Sponsor Name

Sponsor Name for Progesterone
Sponsor	Trials
National Cancer Institute (NCI)	104
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	38
Cairo University	17

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Progesterone
Sponsor	Trials
Other	948
Industry	222
NIH	203

Export unavailable in trial.
Subscribe for complete access.